Dendritic Cell-Based HIV Therapeutic Vaccine Increases Residual Viremia in Individuals on ART
Background: We evaluated the impact of therapeutic vaccination with an autologous dendritic cell (DC) vaccine pulsed with autologous, inactivated HIV-1-infected apoptotic cells on the level of residual plasma viremia in individuals on suppressive antiretroviral therapy (ART) and following analytic treatment interruption (ATI). Methodology: Autologous HIV-1 was obtained from 10 ART-naive subjects prior to starting ART.…